FDA urges OTC medicine sellers to comply with regulations  

By Godfred Aaneamenga Polkuu, GNA  

Navrongo (U/E), Nov. 11, GNA – The Food and Drugs Authority (FDA) has urged over the counter (OTC) medicine sellers in the Upper East Region to strictly adhere to regulatory requirements and best practices to safeguard the quality, safety and efficacy of medicines sold to members of the public.  

The Authority said compliance with established standards, including the sale of registered medicines and proper storage practices, was critical to protecting consumers and ensuring that medicines deliver their intended therapeutic benefits.  

Mr Abel Ndego, the Acting Upper East Regional Head of the FDA, made the call in an interview with the Ghana News Agency (GNA) after an engagement with OTC medicine sellers in the Kassena-Nankana Municipality and Kassena-Nankana West District.   

The engagement was aimed at strengthening OTC operators understanding of regulatory requirements and promote responsible pharmaceutical practices.  

Participants were taken through relevant provisions of the Public Health Act, with emphasis on ensuring that all medicines and medical devices sold at their facilities were duly registered by the FDA and had the requisite marketing authorization.  

The engagement further highlighted the importance of proper medicine storage, with the Authority warning that inappropriate storage conditions could compromise the quality and effectiveness of pharmaceutical products.  

Mr Ndego said OTC medicine sellers played a significant role in the healthcare delivery system because of their accessibility to people, particularly in communities where access to other healthcare facilities could be limited.  

“They play a very significant role in this particular regulatory space. They are mostly located in the communities where a lot of the citizens access their services,” the Acting Head said.  

He said improper storage could cause active pharmaceutical ingredients in medicines to diminish or, in some instances, become virtually absent, thereby depriving consumers of the expected therapeutic benefits.  

“When unsuspecting clients consume these things, they are not able to benefit from the therapeutic effects that these medicines are supposed to be eliciting when they are consumed,” he cautioned.  

The FDA further educated participants on how to verify the registration status of medicines and encouraged them to operate within the regulatory framework governing their businesses.  

Another key area Mr Ndego addressed was pharmacovigilance, particularly the monitoring and reporting of adverse reactions associated with medicines and vaccines.  

He encouraged OTC medicine sellers to promptly report suspected adverse reactions to enable the Authority to investigate their causes and work with manufacturers to introduce appropriate interventions where necessary.  

Participants were specifically encouraged to download and use the FDA’s MedSafety App, which facilitates the reporting of adverse events associated with medicines and vaccines from anywhere in the country.  

The application also provides users with relevant information on medicine safety.  

Mr Ndego explained that credible reports would provide scientific evidence to support regulatory decisions and contribute to improving the quality and safety of medicines and vaccines.  

“Our passionate agenda are to make Upper East the most regulatory compliant region, and we are committed to this vision,” he stated.   

GNA 

Edited by Caesar Abagali/Benjamin Mensah